Johnson & Johnson (JNJ)
Debt-to-equity ratio
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | 30,651,000 | 25,881,000 | 26,886,000 | 29,985,000 | 32,635,000 |
Total stockholders’ equity | US$ in thousands | 71,490,000 | 68,774,000 | 76,804,000 | 74,023,000 | 63,278,000 |
Debt-to-equity ratio | 0.43 | 0.38 | 0.35 | 0.41 | 0.52 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $30,651,000K ÷ $71,490,000K
= 0.43
Johnson & Johnson's debt-to-equity ratio has shown a decreasing trend over the past five years, starting at 0.52 in 2020 and dropping to 0.41 in 2021, 0.35 in 2022, 0.38 in 2023, and then increasing slightly to 0.43 in 2024. This indicates that the company has been relying less on debt to finance its operations and growth, and has been increasingly using equity. A lower debt-to-equity ratio is generally considered favorable as it suggests lower financial risk and a stronger financial position. However, the slight increase in 2024 could indicate a shift in the company's financing strategy. Overall, Johnson & Johnson's decreasing debt-to-equity ratio reflects a prudent approach to balancing its capital structure.
Peer comparison
Dec 31, 2024